Treatment with interleukin-2 in an immunodepressed state.

Cytotoxic T-lymphocyte (CTL) and lymphokine activated killer (LAK) cell (fraction II) precursors with a density of 1.077-1.067 g/ml and suppressor cells (fraction I) with a density of 1.